Krilogy Financial’s Array Biopharma Inc ARRY Stock Holding History

Krilogy Financial’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-300	Closed	-$5K	–	804
2018 Q3	$5K	Buy	+300	New	+$4.6K	﹤0.01%	634
2018 Q2	–	Sell	-300	Closed	-$5K	–	720
2018 Q1	$5K	Buy	300 +100	+50%	+$1.6K	﹤0.01%	614
2017 Q4	$3K	Hold	200	–	–	﹤0.01%	666
2017 Q3	$2K	Sell	200 -100	-33%	-$929	﹤0.01%	758
2017 Q2	$3K	Sell	300 -200	-40%	-$1.64K	﹤0.01%	652
2017 Q1	$4K	Hold	500	–	–	﹤0.01%	608
2016 Q4	$4K	Hold	500	–	–	﹤0.01%	608
2016 Q3	$3K	Hold	500	–	–	﹤0.01%	652
2016 Q2	$2K	Hold	500	–	–	﹤0.01%	696
2016 Q1	$1K	Hold	500	–	–	﹤0.01%	672
2015 Q4	$2K	Hold	500	–	–	﹤0.01%	391
2015 Q3	$2K	Buy	+500	New	+$2.96K	﹤0.01%	561

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Krilogy Financial's ARRY Position: Q4 2018 in Review

Krilogy Financial sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 300 shares — an estimated $5K sold.

Krilogy Financial first reported a position in ARRY in Q3 2015 and held it in 12 quarters. The position peaked at $5K in Q3 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

Krilogy Financial reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 300 Array Biopharma Inc shares in Q4 2018, an estimated $5K.
Krilogy Financial first reported a position in Array Biopharma Inc in Q3 2015 and held it in 12 quarters.
Krilogy Financial's Array Biopharma Inc position peaked at $5K in Q3 2018.
236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.